Colon Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colon Cancer, including details on causes, treatment, symptoms.

Volume 2 (2005), Issue 2 (February)

1. Identification and phenotypic characterization of a subpopulation of T84 human colon cancer cells, after selection on activated endothelial cells.
   J Cell Physiol, 203(1): 261-72. [Abstract] [Full-text]
2. The double-barreled wet ileostomy: an alternative method for simultaneous urinary and intestinal diversion without intestinal anastomosis after total colectomy and pelvic exenteration.
   Int J Colorectal Dis, 20(2): 190-3. [Abstract] [Full-text]
3. Foxl1 is a mesenchymal Modifier of Min in carcinogenesis of stomach and colon.
   Genes Dev, 19(3): 311-5. [Abstract] [Full-text]
4. Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study.
   Int J Colorectal Dis, 20(2): 147-54. [Abstract] [Full-text]
5. Bile salt-induced apoptosis in human colon cancer cell lines involves the mitochondrial transmembrane potential but not the CD95 (Fas/Apo-1) receptor.
   Int J Colorectal Dis, 20(2): 103-13. [Abstract] [Full-text]
6. Redefining the subcellular location and transport of APC: new insights using a panel of antibodies.
   EMBO Rep, 6(2): 184-90. [Abstract] [Full-text]
7. Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma.
   J Clin Invest, 115(2): 339-47. [Abstract] [Full-text]
8. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer.
   Oncogene, 24(6): 1098-103. [Abstract] [Full-text]
9. Dual-channel photobleaching FRET microscopy for improved resolution of protein association states in living cells.
   Eur Biophys J, 34(1): 82-90. [Abstract] [Full-text]
10. The use of endoscopic ultrasound-guided fine-needle aspiration for investigation of submucosal and extrinsic masses of the colon and rectum.
    Endoscopy, 37(2): 154-60. [Abstract] [Full-text]
11. Dietary patterns and colorectal adenomas in Japanese men: the Self-Defense Forces Health Study.
    Am J Epidemiol, 161(4): 338-45. [Abstract] [Full-text]
12. Iron deficiency anemia in patients without gastrointestinal symptoms--a prospective study.
    Fam Pract, 22(1): 58-61. [Abstract] [Full-text]
13. Carcinoembryonic antigen antibody inhibits lung metastasis and augments chemotherapy in a human colonic carcinoma xenograft.
    Cancer Immunol Immunother, 54(4): 315-27. [Abstract] [Full-text]
14. Locoreginal radioimmunotherapy with 186Re-labeled monoclonal antibody in treating small peritoneal carcinomatosis of colon cancer in mice in comparison with 131I-counterpart.
    Cancer Lett, 219(1): 41-8. [Abstract] [Full-text]
15. Gastrin promotes human colon cancer cell growth via CCK-2 receptor-mediated cyclooxygenase-2 induction and prostaglandin E2 production.
    Br J Pharmacol, 144(3): 338-48. [Abstract] [Full-text]
16. Heparanase expression correlates with malignant potential in human colon cancer.
    J Cancer Res Clin Oncol, 131(4): 229-37. [Abstract] [Full-text]
17. Cytotoxic and antiangiogenic activity of AW464 (NSC 706704), a novel thioredoxin inhibitor: an in vitro study.
    Br J Cancer, 92(2): 350-8. [Abstract] [Full-text]
18. Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, PEGylated di-Fab', leads to fluid accumulation and is associated with increased tumor vascularized volume.
    J Clin Oncol, 23(5): 973-81. [Abstract] [Full-text]
19. Solar radiation, vitamin D and survival rate of colon cancer in Norway.
    J Photochem Photobiol B, 78(3): 189-93. [Abstract] [Full-text]
20. Citri Reticulatae Viride Pericarpium extract induced apoptosis in SNU-C4, human colon cancer cells.
    J Ethnopharmacol, 97(2): 231-5. [Abstract] [Full-text]
21. Antitumour imidazoacridone C-1311 induces cell death by mitotic catastrophe in human colon carcinoma cells.
    Biochem Pharmacol, 69(5): 801-9. [Abstract] [Full-text]
22. Morpholino antisense oligomer targeting human midkine: its application for cancer therapy.
    Int J Cancer, 114(3): 490-7. [Abstract] [Full-text]
23. Overexpression of RGC-32 in colon cancer and other tumors.
    Exp Mol Pathol, 78(2): 116-22. [Abstract] [Full-text]
24. Cytotoxic activities of chitosan nanoparticles and copper-loaded nanoparticles.
    Bioorg Med Chem Lett, 15(5): 1397-9. [Abstract] [Full-text]
25. Antitumor effects of radioiodinated antisense oligonuclide mediated by VIP receptor.
    Cancer Gene Ther, 12(3): 313-20. [Abstract] [Full-text]
26. Positional isomerism markedly affects the growth inhibition of colon cancer cells by nitric oxide-donating aspirin in vitro and in vivo.
    J Pharmacol Exp Ther, 312(3): 978-88. [Abstract] [Full-text]
27. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers.
    J Cell Biol, 168(4): 633-42. [Abstract] [Full-text]
28. The risk of metachronous neoplasia in patients with serrated adenoma.
    Am J Clin Pathol, 123(3): 349-59. [Abstract] [Full-text]
29. The in vivo characteristics of genetically engineered divalent and tetravalent single-chain antibody constructs.
    Nucl Med Biol, 32(2): 157-64. [Abstract] [Full-text]
30. 3',5'-Cyclic diguanylic acid (c-di-GMP) inhibits basal and growth factor-stimulated human colon cancer cell proliferation.
    Biochem Biophys Res Commun, 329(1): 40-5. [Abstract] [Full-text]
31. Free radical scavenging and apoptotic effects of Cordyceps sinensis fractionated by supercritical carbon dioxide.
    Food Chem Toxicol, 43(4): 543-52. [Abstract] [Full-text]
32. Quinoxaline 1,4-dioxides induce G2/M cell cycle arrest and apoptosis in human colon cancer cells.
    Cancer Chemother Pharmacol, 55(4): 369-78. [Abstract] [Full-text]
33. Extracolonic manifestations of familial adenomatous polyposis after proctocolectomy.
    Arch Surg, 140(2): 159-63; discussion 164. [Abstract] [Full-text]
34. Beta-Catenin mutations in a mouse model of inflammation-related colon carcinogenesis induced by 1,2-dimethylhydrazine and dextran sodium sulfate.
    Cancer Sci, 96(2): 69-76. [Abstract] [Full-text]
35. Genetics of hereditary colorectal cancer.
    Semin Oncol, 32(1): 11-23. [Abstract] [Full-text]
36. Antitumour activity of XR5944 in vitro and in vivo in combination with 5-fluorouracil and irinotecan in colon cancer cell lines.
    Br J Cancer, 92(4): 722-8. [Abstract] [Full-text]
37. Chromosomal instability in flat adenomas and carcinomas of the colon.
    J Pathol, 205(4): 514-21. [Abstract] [Full-text]
38. Augmentation of differentiation and gap junction function by kaempferol in partially differentiated colon cancer cells.
    Carcinogenesis, 26(3): 665-71. [Abstract] [Full-text]
39. Dietary folate intake and k-ras mutations in sporadic colon and rectal cancer in The Netherlands Cohort Study.
    Int J Cancer, 114(5): 824-30. [Abstract] [Full-text]
40. Colon polyps and cancer.
    Endoscopy, 37(3): 208-12. [Abstract] [Full-text]
41. Identification of Src-specific phosphorylation site on focal adhesion kinase: dissection of the role of Src SH2 and catalytic functions and their consequences for tumor cell behavior.
    Cancer Res, 65(4): 1335-42. [Abstract] [Full-text]
42. Oncogenic K-RAS is required to maintain changes in cytoskeletal organization, adhesion, and motility in colon cancer cells.
    Cancer Res, 65(4): 1244-50. [Abstract] [Full-text]
43. Diet, lifestyle, and genomic instability in the North Carolina Colon Cancer Study.
    Cancer Epidemiol Biomarkers Prev, 14(2): 429-36. [Abstract] [Full-text]
44. Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: a multivariate analysis.
    J Surg Oncol, 89(4): 211-7. [Abstract] [Full-text]
45. Identification of defensin alpha6 as a potential biomarker in colon adenocarcinoma.
    J Biol Chem, 280(9): 8260-5. [Abstract] [Full-text]
46. Fluoxetine increases extracellular levels of 3-methoxy-4-hydroxyphenylglycol in cultured COLO320 DM cells.
    Cell Biochem Funct, 23(2): 109-14. [Abstract] [Full-text]
47. DRO1, a gene down-regulated by oncogenes, mediates growth inhibition in colon and pancreatic cancer cells.
    J Biol Chem, 280(9): 7962-75. [Abstract] [Full-text]

© 2004-2008 Colon Cancer Research Today. All Rights Reserved.